Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Am J Alzheimers Dis Other Demen. 2012 Dec 26;28(2):179–184. doi: 10.1177/1533317512470484

Table 2.

Demographic Information and Neuropsychological Performance Scores for aMCI and CON subjects sorted by Conversion Status (CONV = Converters; NONCONV = Nonconverters)

Measure CONV NONCONV t tests
Total N 17 [4/13] 75 [56/19] ns
Age 67.4 (9.2) 70.5 (6.9) ns
Education 15.2 (3.4) 15.7 (2.7) ns
CERAD1
  Animal Fluency 15.5 (5.1) 19.3 (5.2) t = 2.71, p = .008
  Boston Naming Test 25.7 (3.2) 26.3 (3.7) ns
Mini-Mental State Exam 27.4 (1.8) 28.8 (1.5) t = 3.27, p = .002
Word List Memory (WLM)2
  WLM total 14.7 (4.3) 21.4 (4.5) t = 5.18, p < .0001
  WLM delayed recall 3.4 (2.0) 6.6 (2.5) t = 4.67, p < .0001
Trail Making Test (TMT)
  TMT-A 51.7 (20.3) 36.2 (14.7) t = 3.63, p = .0005
  TMT-B3,4 140.9 (75.1) 95.6 (45.6) t = 3.15, p = .002
Digit Span Forward 8.3 (1.7) 8.7 (1.8) ns
Digit Span Backward 5.9 (2.4) 6.7 (2.0) ns
Clock Drawing Test 12.0 (0.9) 12.3 (0.9) ns
Geriatric Depression Scale5 2.9 (2.7) 1.6 (1.9) t = 2.18, p = .032

Eye tracking variables (2-min delay)
Familiarization phase
 Total number of fixations 14.7 (1.9) 14.4 (2.3) ns
 Total Looking Time (secs) 3.9 (0.5) 4.0 (0.5) ns
Test phase
 % Looking Time on Novel 53.3 (7.8) 68.9 (8.6) t = 6.82, p < .0001
 Total number of fixations 13.6 (2.5) 13.6 (2.4) ns
 Total Looking Time (secs) 3.9 (0.6) 4.1 (0.5) ns

Brackets indicate [CON/aMCI]; The mean for each variable is given with standard deviations in parentheses

1

CERAD = Consortium to Establish a Registry for Alzheimer’s disease

2

WLM: 23 subjects (CONV = 2; NONCONV = 21) were not administered the WLM test

3

indicates the variances are not equal and differ significantly

4

TMT-B: 5 subjects (CONV = 1; NONCONV = 4) did not complete the test in the allotted timeframe. Scores for these subjects are not included in the TMT-B score

5

GDS: 4 subjects (CONV = 1; NONCONV = 3) were not administered the GDS